Targeting HER2-positive breast cancer: advances and future directions von Swain, Sandra M., Shastry, Mythili, Hamilton, Erika

Volltext

HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now von Schlam, Ilana, Swain, Sandra M.

Volltext

Novel anticancer targets: revisiting ERBB2 and discovering ERBB3 von Baselga, José, Swain, Sandra M

Volltext

Luminal A Breast Cancer and Molecular Assays: A Review von Gao, Jennifer J., Swain, Sandra M.

Volltext

Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the... von Luen, Stephen J, MBChB, Salgado, Roberto, MD, Fox, Stephen, Prof, Savas, Peter, MBBS, Eng-Wong, Jennifer, MD, Clark, Emma, MSc, Kiermaier, Astrid, PhD, Swain, Sandra M, MD, Baselga, Jose, MD, Michiels, Stefan, PhD, Loi, Sherene, Dr

Volltext

Could Some Reports of Trastuzumab Cardiotoxicity Be a Surveillance Artifact? von Ewer, Michael S, Swain, Sandra M

Volltext

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N98... von Perez, Edith A, Romond, Edward H, Suman, Vera J, Jeong, Jong-Hyeon, Sledge, George, Geyer, Jr, Charles E, Martino, Silvana, Rastogi, Priya, Gralow, Julie, Swain, Sandra M, Winer, Eric P, Colon-Otero, Gerardo, Davidson, Nancy E, Mamounas, Eleftherios, Zujewski, Jo Anne, Wolmark, Norman

Volltext

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, p... von Swain, Sandra M, Dr, Kim, Sung-Bae, MD, Cortés, Javier, MD, Ro, Jungsil, MD, Semiglazov, Vladimir, MD, Campone, Mario, MD, Ciruelos, Eva, MD, Ferrero, Jean-Marc, MD, Schneeweiss, Andreas, MD, Knott, Adam, PhD, Clark, Emma, MSc, Ross, Graham, FFPM, Benyunes, Mark C, MD, Baselga, José, MD

Volltext

CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunities von Lynce, Filipa, Shajahan-Haq, Ayesha N., Swain, Sandra M.

Volltext

Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer von Baselga, José, Cortés, Javier, Im, Seock-Ah, Clark, Emma, Ross, Graham, Kiermaier, Astrid, Swain, Sandra M

Volltext

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer von Swain, Sandra M, Baselga, José, Kim, Sung-Bae, Ro, Jungsil, Semiglazov, Vladimir, Campone, Mario, Ciruelos, Eva, Ferrero, Jean-Marc, Schneeweiss, Andreas, Heeson, Sarah, Clark, Emma, Ross, Graham, Benyunes, Mark C, Cortés, Javier

Volltext

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials von Taylor, Carolyn, Correa, Candace, Duane, Frances K, Aznar, Marianne C, Anderson, Stewart J, Bergh, Jonas, Dodwell, David, Ewertz, Marianne, Gray, Richard, Jagsi, Reshma, Pierce, Lori, Pritchard, Kathleen I, Swain, Sandra, Wang, Zhe, Wang, Yaochen, Whelan, Tim, Peto, Richard, McGale, Paul

Volltext

NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and Wit... von Fehrenbacher, Louis, Cecchini, Reena S, Geyer, Jr, Charles E, Rastogi, Priya, Costantino, Joseph P, Atkins, James N, Crown, John P, Polikoff, Jonathan, Boileau, Jean-Francois, Provencher, Louise, Stokoe, Christopher, Moore, Timothy D, Robidoux, André, Flynn, Patrick J, Borges, Virginia F, Albain, Kathy S, Swain, Sandra M, Paik, Soonmyung, Mamounas, Eleftherios P, Wolmark, Norman

Volltext

Post-CDK 4/6 Inhibitor Therapy: Current Agents and Novel Targets von Ashai, Nadia, Swain, Sandra M

Volltext

Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology) von Blum, Joanne L, Flynn, Patrick J, Yothers, Greg, Asmar, Lina, Geyer, Jr, Charles E, Jacobs, Samuel A, Robert, Nicholas J, Hopkins, Judith O, O'Shaughnessy, Joyce A, Dang, Chau T, Gómez, Henry Leonidas, Fehrenbacher, Louis, Vukelja, Svetislava J, Lyss, Alan P, Paul, Devchand, Brufsky, Adam M, Jeong, Jong-Hyeon, Colangelo, Linda H, Swain, Sandra M, Mamounas, Eleftherios P, Jones, Stephen E, Wolmark, Norman

Volltext

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer von Baselga, José, Cortés, Javier, Kim, Sung-Bae, Im, Young-Hyuck, Im, Seock-Ah, Hegg, Roberto, Roman, Laslo, Pedrini, José Luiz, Pienkowski, Tadeusz, Knott, Adam, Clark, Emma, Benyunes, Mark C, Ross, Graham, Swain, Sandra M

Volltext

Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzu... von ROMOND, Edward H, JEONG, Jong-Hyeon, FLYNN, Patrick J, ZAPAS, John L, POLIKOFF, Jonathan, GROSS, Howard M, BIGGS, David D, ATKINS, James N, TAN-CHIU, Elizabeth, PING ZHENG, YOTHERS, Greg, MAMOUNAS, Eleftherios P, RASTOGI, Priya, WOLMARK, Norman, SWAIN, Sandra M, GEYER, Charles E, EWER, Michael S, RATHI, Vikas, FEHRENBACHER, Louis, BRUFSKY, Adam, AZAR, Catherine A

Volltext

Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial von Robidoux, André, Prof, Tang, Gong, PhD, Rastogi, Priya, MD, Geyer, Charles E, Prof, Azar, Catherine A, MD, Atkins, James N, MD, Fehrenbacher, Louis, MD, Bear, Harry D, MD, Baez-Diaz, Louis, MD, Sarwar, Shakir, MD, Margolese, Richard G, MD, Farrar, William B, Prof, Brufsky, Adam M, Prof, Shibata, Henry R, Prof, Bandos, Hanna, PhD, Paik, Soonmyung, Prof, Costantino, Joseph P, Prof, Swain, Sandra M, Prof, Mamounas, Eleftherios P, Prof, Wolmark, Norman, Prof

Volltext

Peripheral Neuropathy Induced by Microtubule-Stabilizing Agents von LEE, James J, SWAIN, Sandra M

Volltext

Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24 von CRAIG ALLRED, D, ANDERSON, Stewart J, LAND, Stephanie R, WOLMARK, Norman, PAIK, Soonmyung, LAWRENCE WICKERHAM, D, NAGTEGAAL, Iris D, SWAIN, Sandra M, MAMOUNAS, Elefetherios P, JULIAN, Thomas B, GEYER, Charles E, COSTANTINO, Joseph P

Volltext